Rockfield Medical Devices Limited Receives CE Mark Approval for the Mobility+® Enteral Feeding System, Marking a Major Milestone in Global Commercial Expansion
GALWAY, COUNTY GALWAY, IRELAND, January 7, 2026 /EINPresswire.com/ — Rockfield Medical Devices Limited, a leader in innovative enteral feeding solutions, today announced that it has received CE (Conformité Européenne) Mark approval in the European Union (EU) for its flagship product, the Mobility+® Elastomeric Enteral Feeding System. The CE Mark enables the commercial distribution of Mobility+® Enteral Feeding System throughout the European Union and other CE-recognizing markets.
The Mobility+® Enteral Feeding System is the world’s first elastomeric enteral feeding solution designed to enhance patient mobility, comfort, and quality of life. Unlike conventional enteral feeding systems, Mobility+® provides a silent, electricity-free, wearable alternative that supports greater independence for patients requiring long-term or home-based nutritional support.
“We are thrilled to receive CE Mark approval for Mobility+®, a major milestone in Rockfield’s mission to empower active feeding for patients around the world,” said Tomas Thompson, CEO of Rockfield Medical Devices. “This regulatory achievement reflects the team’s hard work, close collaboration with clinicians and patients, and our commitment to addressing long-standing unmet needs in enteral nutrition. With CE Mark certification, we can now bring Mobility+® to patients and healthcare providers throughout Europe and beyond.”
The CE Mark follows Rockfield’s successful attainment of FDA Over-the-Counter (OTC) clearance in the United States, underscoring the company’s expanding global regulatory footprint. Together, these clearances position Rockfield to execute its commercial strategy across major developed markets, including the United States, the European Union and the EEA, as well as other international regions.
Clinical and real-world use of Mobility+® has demonstrated strong acceptance among patients, caregivers, and clinicians, with reported improvements in feeding tolerance, ease of use, and overall quality of life.
“We have seen firsthand the transformative impact Mobility+® has on patients and caregivers in the United States,” said Peter Mulrooney, Chairperson of Rockfield Medical Devices, “CE Mark approval allows Rockfield to extend these benefits to patients across Europe and other global markets. This milestone enables the next phase of Rockfield’s growth and supports our vision to redefine the standard of care in enteral feeding.”
About Rockfield Medical Devices
Rockfield Medical Devices is a medical technology company dedicated to improving the lives of individuals who require enteral feeding. The company’s flagship product, Mobility+®, provides a mobile, silent, and user-centered alternative to traditional enteral feeding systems. Rockfield’s mission is to empower active feeding and enhance independence, comfort, and quality of life for patients and caregivers worldwide.
For more information, visit www.rockfieldmd.com.
Tomas Thompson
Rockfield Medical Devices
+353 91 763 000
info@rockfieldmd.com
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
Mobility+ Video
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
